Redcare Pharmacy NV (ETR:RDC)
Germany flag Germany · Delayed Price · Currency is EUR
68.40
-1.65 (-2.36%)
Nov 13, 2026, 5:35 PM CET

Redcare Pharmacy NV Statistics

Total Valuation

ETR:RDC has a market cap or net worth of EUR 1.41 billion. The enterprise value is 1.65 billion.

Market Cap1.41B
Enterprise Value 1.65B

Important Dates

The last earnings date was Thursday, October 29, 2026.

Earnings Date Oct 29, 2026
Ex-Dividend Date n/a

Share Statistics

ETR:RDC has 20.58 million shares outstanding.

Current Share Class 20.58M
Shares Outstanding 20.58M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 4.53%
Owned by Institutions (%) 30.63%
Float 19.65M

Valuation Ratios

PE Ratio n/a
Forward PE 75.01
PS Ratio 0.42
PB Ratio 2.96
P/TBV Ratio 19.69
P/FCF Ratio n/a
P/OCF Ratio 28.94
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.49
EV / EBITDA 42.86
EV / EBIT 155.65
EV / FCF n/a

Financial Position

The company has a current ratio of 1.62, with a Debt / Equity ratio of 0.74.

Current Ratio 1.62
Quick Ratio 0.81
Debt / Equity 0.74
Debt / EBITDA 9.40
Debt / FCF n/a
Interest Coverage 0.31

Financial Efficiency

Return on equity (ROE) is -7.07% and return on invested capital (ROIC) is 0.70%.

Return on Equity (ROE) -7.07%
Return on Assets (ROA) 0.52%
Return on Invested Capital (ROIC) 0.70%
Return on Capital Employed (ROCE) 1.20%
Weighted Average Cost of Capital (WACC) 11.20%
Revenue Per Employee 1.55M
Profits Per Employee -15,719
Employee Count2,163
Asset Turnover 2.82
Inventory Turnover 13.90

Taxes

In the past 12 months, ETR:RDC has paid 4.20 million in taxes.

Income Tax 4.20M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +6.21% in the last 52 weeks. The beta is 1.45, so ETR:RDC's price volatility has been higher than the market average.

Beta (5Y) 1.45
52-Week Price Change +6.21%
50-Day Moving Average 68.38
200-Day Moving Average 58.28
Relative Strength Index (RSI) 43.39
Average Volume (20 Days) 63,597

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ETR:RDC had revenue of EUR 3.34 billion and -34.00 million in losses.

Revenue3.34B
Gross Profit 719.40M
Operating Income 9.80M
Pretax Income -31.10M
Net Income -34.00M
EBITDA 30.50M
EBIT 9.80M
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

The company has 132.40 million in cash and 354.50 million in debt, with a net cash position of -222.10 million or -10.79 per share.

Cash & Cash Equivalents 132.40M
Total Debt 354.50M
Net Cash -222.10M
Net Cash Per Share -10.79
Equity (Book Value) 476.50M
Book Value Per Share n/a
Working Capital 208.80M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 48.70 million and capital expenditures -55.90 million, giving a free cash flow of -7.20 million.

Operating Cash Flow 48.70M
Capital Expenditures -55.90M
Depreciation & Amortization 20.70M
Net Borrowing -76.20M
Free Cash Flow -7.20M
FCF Per Share -0.35
Full Cash Flow Statement

Margins

Gross margin is 21.51%, with operating and profit margins of 0.29% and -1.02%.

Gross Margin 21.51%
Operating Margin 0.29%
Pretax Margin -0.93%
Profit Margin -1.02%
EBITDA Margin 0.91%
EBIT Margin 0.29%
FCF Margin n/a

Dividends & Yields

ETR:RDC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -2.41%
FCF Yield -0.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Analyst Forecast

The average price target for ETR:RDC is 91.60, which is 33.92% higher than the current price. The consensus rating is "Buy".

Price Target 91.60
Price Target Difference 33.92%
Analyst Consensus Buy
Analyst Count 10
Revenue Growth Forecast (3Y) 13.07%
EPS Growth Forecast (3Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 4